BioAdaptivesBDPT -28.50% 3-Year RORE % is 0.82 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 1,829 Consumer Packaged Goods companies, BioAdaptives ranks worse than 54.67% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
BioAdaptives's 3-Year RORE % for the quarter that ended in Mar. 2026 was 0.82%.
The industry rank for BioAdaptives's 3-Year RORE % or its related term are showing as below:
BDPT's 3-Year RORE % is ranked worse than 54.67% of 1829
companies
in the Consumer Packaged Goods industry
Industry Median: 6.01
vs BDPT: 0.82
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
BioAdaptives 3-Year RORE % Related Terms
BioAdaptives 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for BioAdaptives's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BDPT vs NBND, BSFC, MEHA: 3-Year RORE % Comparison
For the Packaged Foods subindustry, BioAdaptives's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioAdaptives 3-Year RORE % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where BioAdaptives's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
BioAdaptives (BDPT) has a 3-Year RORE % of 0.82 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BioAdaptives and its competitors. According to the industry distribution chart, BioAdaptives ranks #1000 out of 1829 companies in the Consumer Packaged Goods industry, placing it in the top 54.7%.
Is BioAdaptives' 3-Year RORE % too high?
BioAdaptives' current 3-Year RORE % is 0.82. The Consumer Packaged Goods industry median 3-Year RORE % is 6.01. BioAdaptives' value of 0.82 is 86.4% below this industry median. Based on the distribution chart, BioAdaptives ranks #1000 out of 1829 companies in the Consumer Packaged Goods industry, which is below the industry midpoint.
How does BioAdaptives' 3-Year RORE % compare to NBND and BSFC?
According to the Consumer Packaged Goods industry distribution chart, BioAdaptives ranks #1000 out of 1829 companies for 3-Year RORE %. This places BioAdaptives in the lower half of its industry. The industry median 3-Year RORE % is 6.01. BioAdaptives' value of 0.82 is 86.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Consumer Packaged Goods company?
The median 3-Year RORE % among Consumer Packaged Goods companies is 6.01, based on 1,829 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioAdaptives's current 3-Year RORE % of 0.82 is 86.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BioAdaptives and its competitors. For the Consumer Packaged Goods industry, the median 3-Year RORE % is 6.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioAdaptives's current 3-Year RORE % is 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioAdaptives stock overvalued right now?
BioAdaptives (BDPT) has a current 3-Year RORE % of 0.82. The current 3-Year RORE % is 0.82 and 86.4% below the Consumer Packaged Goods industry median of 6.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For BioAdaptives (BDPT), the current 3-Year RORE % is 0.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDPT has been successfully added to your 